HIPRA recently participated in the American Association of Avian Pathologists (AAAP) Annual Meeting, a major event for poultry health professionals in North America and neighboring countries, which took place in St. Louis (Missouri) from July 9^th to 11^th.

The AAAP congress provides valuable insights into the poultry health landscape in the US and Canada. Additionally, it offers a platform for networking with key players from across the American continent, including researchers, producers, and poultry consultants. HIPRA Canada staff connected with key Canadian poultry producers and veterinarians, leveraging the influence of the US market and offering our entire poultry portfolio in the country.

As part of the “Experiences Challenge” for in-ovo coccidiosis vaccines, organized by HIPRA, two winners from Belgium and Spain showcased successful EVANOVO® trials, strengthening our relationships with partners. Additionally, an oral presentation on EVANOVO®'s performance in field conditions was given by Joan Molist (Global Product Manager Poultry, HIPRA). The talk provided an opportunity to introduce HIPRA to the US poultry community and highlight the benefits of our technology and its advancements in coccidiosis control.

HIPRA's participation in the AAAP congress demonstrates the company's commitment to the North American poultry market. The AAAP is an ideal platform for other American countries to showcase HIPRA's expertise and EVANOVO®'s potential for broiler performance, as well as to connect with local organizations and producers. By building relationships and creating awareness, HIPRA establishes a strong presence in this crucial market.